Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Entero Healthcare SolutionsNSE:ENTERO +5.83%43 Return-on-Tangible-Asset is 3.94% as of Mar. 2026, which is 516% above its 10-year median of 0.64. GuruFocus rates NSE:ENTERO with a GF Score™ of 43/100. The stock has 5 warning signs investors should review. Among 120 Medical Distribution companies, Entero Healthcare Solutions ranks better than 70.83% on this metric.
Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Entero Healthcare Solutions's annualizedNet Income for the quarter that ended in Mar. 2026 was ₹1,120 Mil. Entero Healthcare Solutions's average total tangible assets for the quarter that ended in Mar. 2026 was ₹28,402 Mil. Therefore, Entero Healthcare Solutions's annualized Return-on-Tangible-Asset for the quarter that ended in Mar. 2026 was 3.94%.
The historical rank and industry rank for Entero Healthcare Solutions's Return-on-Tangible-Asset or its related term are showing as below:
NSE:ENTERO'
s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: -3.5 Med: 0.64 Max: 4.6
Current: 4.6
During the past 6 years, Entero Healthcare Solutions's highest Return-on-Tangible-Asset was 4.60%. The lowest was -3.50%. And the median was 0.64%.
NSE:ENTERO's Return-on-Tangible-Asset is ranked better than 70.83% of 120
companies
in the Medical Distribution industry
Industry Median: 2.38
vs NSE:ENTERO: 4.60
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companys earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companys tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
Entero Healthcare Solutions Return-on-Tangible-Asset Related Terms
Entero Healthcare Solutions Return-on-Tangible-Asset Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:ENTERO vs MCK, COR, CAH: Return-on-Tangible-Asset Comparison
For the Medical Distribution subindustry, Entero Healthcare Solutions's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Entero Healthcare Solutions Return-on-Tangible-Asset vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Entero Healthcare Solutions's Return-on-Tangible-Asset distribution charts can be found below:
* The bar in red indicates where Entero Healthcare Solutions's Return-on-Tangible-Asset falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Mar. 2026) net income data.
What does a Return-on-Tangible-Asset of 3.94% mean?
Entero Healthcare Solutions (NSE:ENTERO) has a Return-on-Tangible-Asset of 3.94% as of Mar. 2026. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Entero Healthcare Solutions and its competitors. This is 516% above median its historical median of 0.64. According to the industry distribution chart, Entero Healthcare Solutions ranks #35 out of 120 companies in the Medical Distribution industry, placing it in the top 29.2%.
Is Entero Healthcare Solutions' Return-on-Tangible-Asset too high?
Entero Healthcare Solutions' current Return-on-Tangible-Asset of 3.94% is 516% above median its 10-year median of 0.64. The Medical Distribution industry median Return-on-Tangible-Asset is 2.38. Entero Healthcare Solutions' value of 3.94% is 65.5% above this industry median. Based on the distribution chart, Entero Healthcare Solutions ranks #35 out of 120 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, Entero Healthcare Solutions has a GF Score™ of 43/100, reflecting its overall financial health beyond just this single metric.
How does Entero Healthcare Solutions' Return-on-Tangible-Asset compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Entero Healthcare Solutions ranks #35 out of 120 companies for Return-on-Tangible-Asset. This puts Entero Healthcare Solutions in the upper half of its industry. The industry median Return-on-Tangible-Asset is 2.38. Entero Healthcare Solutions' value of 3.94% is 65.5% above this benchmark. While the company's 10-year median is 0.64 vs. the industry median of 2.38, Entero Healthcare Solutions has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a Medical Distribution company?
The median Return-on-Tangible-Asset among Medical Distribution companies is 2.38, based on 120 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Asset significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Entero Healthcare Solutions's current Return-on-Tangible-Asset of 3.94% is 65.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Entero Healthcare Solutions and its competitors. For the Medical Distribution industry, the median Return-on-Tangible-Asset is 2.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Entero Healthcare Solutions's current Return-on-Tangible-Asset is 3.94%, which is 516% above median its own 10-year median of 0.64. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Entero Healthcare Solutions stock overvalued right now?
Entero Healthcare Solutions (NSE:ENTERO) has a current Return-on-Tangible-Asset of 3.94%. The current Return-on-Tangible-Asset is 3.94%, which is 516% above median its 10-year median of 0.64 and 65.5% above the Medical Distribution industry median of 2.38. Entero Healthcare Solutions' overall GF Score™ is 43/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For Entero Healthcare Solutions (NSE:ENTERO), the current Return-on-Tangible-Asset is 3.94% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Entero Healthcare Solutions Ltd is a healthcare products distributor in India. It is involved in the business of distribution and marketing of pharmaceutical and surgical products and allied services. Geographically, the company derives a majority of its revenue from the domestic market.
43GF Score
Get the complete analysis for NSE:ENTERO
Return-on-Tangible-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:ENTERO has been successfully added to your 
